Financhill
Back

Vivos Therapeutics Vs. Kymera Therapeutics Industry Stock Comparison

Sell
40

VVOS
Vivos Therapeutics

Last Price:
2.43
Seasonality Move:
35.01%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Sell
40
Vivos Therapeutics (VVOS) is a Sell

Is Vivos Therapeutics a Buy, Sell or Hold?

  • The current Vivos Therapeutics [VVOS] share price is $2.53. The Score for VVOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VVOS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VVOS Stock Price Chart

What is Vivos Therapeutics's stock price today?

  • The Vivos Therapeutics share price today is $2.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VVOS is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

VVOS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 47.27 Sell
Chaikin Money Flow: 52082 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.37 - 3.15) Sell
Bollinger Bands (100): (2.15 - 2.85) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

VVOS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.43 Buy
20-day SMA: 2.66 Sell
50-day SMA: 2.67 Sell
200-day SMA: 3.57 Sell
8-day EMA: 2.48 Buy
20-day EMA: 2.59 Sell
50-day EMA: 2.64 Sell
200-day EMA: 4.12 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Vivos Therapeutics Earnings Growth & VVOS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.35 per share, and an increase next year of $0.66 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Vivos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):